药品注册申请号:021009
申请类型:NDA (新药申请)
申请人:ALLERGAN
申请人全名:ALLERGAN INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 ALOCRIL NEDOCROMIL SODIUM SOLUTION/DROPS;OPHTHALMIC 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No AT 1999/12/08 1999/12/08 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2016/01/13 SUPPL-11(补充) Approval Manufacturing (CMC) PRIORITY
2008/07/07 SUPPL-10(补充) Approval Labeling STANDARD
2007/08/21 SUPPL-4(补充) Approval Labeling STANDARD
2007/08/21 SUPPL-3(补充) Approval Manufacturing (CMC) PRIORITY
2004/10/18 SUPPL-9(补充) Approval Labeling STANDARD
2004/10/18 SUPPL-8(补充) Approval Manufacturing (CMC) PRIORITY
2002/03/08 SUPPL-2(补充) Approval Manufacturing (CMC) PRIORITY
2000/07/18 SUPPL-1(补充) Approval Manufacturing (CMC) PRIORITY
1999/12/08 ORIG-1(原始申请) Approval Type 3 - New Dosage Form PRIORITY
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
001 4474787 2006/10/02 U-304 PDF格式**本条是由Drugfuture回溯的历史信息**
RE38628 2012/08/22 U-304 PDF格式**本条是由Drugfuture回溯的历史信息**
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:NEDOCROMIL SODIUM 剂型/给药途径:SOLUTION/DROPS;OPHTHALMIC 规格:2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** 治疗等效代码:AT
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021009 001 NDA ALOCRIL NEDOCROMIL SODIUM SOLUTION/DROPS;OPHTHALMIC 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Discontinued Yes No AT 1999/12/08 ALLERGAN
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database